Dr Reddy’s recalls over 8,000 bottles of generic drug in US due to packaging error
时间:2024-06-28 23:38:51 阅读(143)
Dr Reddy’s Laboratories is recalling over 8,000 bottles of a generic medication used to prevent rejection of a transplanted organ from the US market due to a packaging error, according to the US Food & Drug Administration.
The Hyderabad-based drug major is recalling 8,280 bottles of Tacrolimus capsules from the US market for “presence of foreign tablets/capsules” in the affected lot.
The affected lot was produced at Dr Reddy’s Bachupally-based plant near Hyderabad.
New Jersey-based Dr Reddy’s Laboratories, Inc has initiated the nationwide (US) Class II recall on December 15, 2023.
As per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Dr Reddy’s had recalled 4,000 bottles of the same drug in March last year as well. The company had initiated the recall on February 8, 2023.
猜你喜欢
- Lalan Singh quits as JD(U) president, CM Nitish Kumar takes over
- IOC, HPCL, BPCL post Rs 18,480 cr loss in Q1 on holding petrol, diesel prices
- Share Market Highlights- Nifty ends above 18400, Sensex gains 460 pts, Bank Nifty up 0
- IREDA IPO subscribed 38
- Share Market Highlights- Nifty settles at a fresh high; closes above 20260, Sensex over 67480, Bank Nifty adds 330 points
- Largest ever participation of girls cadets in the RD NCC Camp
- Indian shares set to open flat ahead of RBI rate decision
- Share Market Highlights- Nifty tops 18000, Sensex soars 700 pts as bulls return to D-St; HDFC Bank leads gains
- Israel Judicial overhaul- People pack streets in nationwide protests- SEE PHOTOS